SynthesisFrontiers in endocrinology2023

Comparative cardiovascular benefits of individual SGLT2 inhibitors in type 2 diabetes and heart failure: a systematic review and network meta-analysis of randomized controlled trials.

Tanawan Kongmalai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.